Ameriprise’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,729
Closed -$33.1K 4107
2025
Q1
$33.1K Buy
19,729
+2,088
+12% +$5.84K ﹤0.01% 3959
2024
Q4
$28.8K Buy
+17,641
New +$52.6K ﹤0.01% 4036
2024
Q3
Sell
-12,440
Closed -$67.9K 4000
2024
Q2
$67.9K Buy
12,440
+325
+3% +$2.59K ﹤0.01% 3805
2024
Q1
$121K Buy
+12,115
New +$90.8K ﹤0.01% 3761
2023
Q4
Sell
-14,160
Closed -$54.8K 3970
2023
Q3
$54.8K Sell
14,160
-4,215
-23% -$22.7K ﹤0.01% 3832
2023
Q2
$110K Sell
18,375
-57,512
-76% -$331K ﹤0.01% 3807
2023
Q1
$248K Buy
75,887
+31,595
+71% +$126K ﹤0.01% 3664
2022
Q4
$175K Buy
44,292
+459
+1% +$2.25K ﹤0.01% 3732
2022
Q3
$263K Sell
43,833
-391
-0.9% -$2.82K ﹤0.01% 3627
2022
Q2
$285K Buy
44,224
+2,213
+5% +$14.1K ﹤0.01% 3579
2022
Q1
$347K Buy
42,011
+4,871
+13% +$39.4K ﹤0.01% 3594
2021
Q4
$575K Sell
37,140
-1,545
-4% -$29.8K ﹤0.01% 3471
2021
Q3
$871K Buy
38,685
+3,394
+10% +$71.3K ﹤0.01% 3220
2021
Q2
$694K Sell
35,291
-200,768
-85% -$4.55M ﹤0.01% 3345
2021
Q1
$7.9M Buy
+236,059
New +$7.69M ﹤0.01% 2063

Other funds holding SANA